## AMT: American Tower Corporation (REI - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 0.0% below STRENGTH zone (4.0-10.0%); PEG 52.79 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($173.30)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. UBS Maintains American Tower Corp(AMT.US) With Buy Rating, Maintains Target Price $260**
- Source: 富途牛牛 | 20251210T220756 | Bullish | Relevance: 100%
- UBS analyst Batya Levi has reiterated a Buy rating for American Tower Corp (AMT.US), keeping the target price at $260. The analyst's rating comes with a 45.3% success rate and an average return of -3.0% over the past year, according to TipRanks data. This information is intended for informational purposes and not as investment advice.

**2. American Tower (AMT): Valuation Check After Barclays Downgrade Versus Strong Q3 Earnings and Upgraded Guidance**
- Source: Simply Wall Street | 20251210T205359 | Neutral | Relevance: 100%
- American Tower (AMT) recently faced a downgrade from Barclays due to concerns about 2026 growth risks and EchoStar rent exposure, despite a strong Q3 earnings report and upgraded guidance. The stock, currently trading at $179.55, appears undervalued based on its 28.6x P/E ratio compared to peers and an estimated fair P/E of 32.9x, and even more so according to Simply Wall St's DCF model with a fair value estimate of $263.01. Investors are weighing the downgrade's implications against the company's solid earnings performanc and dividend payouts.

**3. National Bank of Canada FI Sells 50,851 Shares of American Tower Corporation $AMT**
- Source: MarketBeat | 20251215T102500 | Neutral | Relevance: 100%
- National Bank of Canada FI has reduced its stake in American Tower Corporation (NYSE:AMT) by selling 50,851 shares, bringing its total ownership to 385,818 shares valued at approximately $85.3 million. This comes as a major shareholder, Tower Corp /Ma/, also executed a significant insider sale of over 2.2 million shares. American Tower recently declared a quarterly dividend of $1.70 per share, with an annualized yield of 3.8%.

**4. Liontrust Investment Partners LLP Sells 36,062 Shares of American Tower Corporation $AMT**
- Source: MarketBeat | 20251214T115321 | Neutral | Relevance: 100%
- Liontrust Investment Partners LLP reduced its stake in American Tower Corporation (NYSE:AMT) by 5.5% in the second quarter, selling 36,062 shares. Despite the sale, the firm still holds 615,322 shares valued at approximately $136 million, making AMT its 11th-largest holding. Meanwhile, American Tower reported strong Q earnings, beating revenue and EPS estimates, and declared a quarterly dividend of $1.70.

**5. Cim Investment Management Inc. Purchases 5,933 Shares of American Tower Corporation $AMT**
- Source: MarketBeat | 20251214T102113 | Somewhat-Bullish | Relevance: 100%
- Cim Investment Management Inc. increased its stake in American Tower Corporation (NYSE:AMT) by 99.6% in the second quarter, acquiring an additional 5,933 shares to hold a total of 11,888 shares valued at $2.403 million. Other institutional investors also adjusted their positions, while American Tower's Director Eugene F. Reilly purchased 5,554 shares and a major shareholder, Tower Corp, sold over 2.2 million shares. Analysts currently rate American Tower as a "Moderate Buy" with a consensus price target of $228.00.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Morgan Stanley | $225 | $235 | -4% |
| 2025-12-01 | Barclays | $200 | $203 | -1% |
| 2025-11-17 | Barclays | $203 | $251 | -19% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Morgan Stanley | main | Overweight |
| 2025-12-01 | Barclays | down | Equal-Weight |
| 2025-11-17 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.99M) |
| Sells | 3 ($159.64M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.6% (+1.0%)
- Blackrock Inc.: 9.7% (-0.6%)
- JPMORGAN CHASE & CO: 6.6% (+142.8%)
- State Street Corpora: 4.5% (-0.9%)
- Cohen & Steers Inc.: 2.9% (-2.9%)

### Key Risks

1. Heavy insider selling: $160M sold (3 transactions in 90 days).
2. Valuation stretched: PEG 52.8x requires aggressive growth execution.
3. Long-term trend broken: trading 11.6% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 52.79 signals overvaluation risk, limited margin of safety. Forward P/E 25.9x attractive for 37% earnings growth. Quality metrics strong (ROE 29%, margin 28%). Analyst sentiment negative (3 target cuts vs 0 raises). Insider selling cluster ($159.6M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $84.6B |
| Beta | 0.92 |
| 52W Range | $172.51 - $234.33 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 52.79 |
| Forward P/E | 25.9 |
| Current P/E | 35.4 |
| YoY Growth | 36.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 0.0% (minimal 5-day change). Below STRENGTH zone by 4.0pp (needs >4.0% for momentum thesis). MRS_5 at 1.1% confirms short-term momentum alignment. Below SMA200 (0.88x), long-term trend not supportive. MACD histogram positive (0.57), confirming momentum. RSI neutral at 49. OFD pattern: -MUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.04% (CS: 38) | Neutral |
| RSI_14 | 49.4 | Neutral |
| MACD Histogram | 0.57 | Bullish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 0.987x | Below |
| vs SMA200 | 0.884x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $180.70
- **Stop Loss:** $173.30 (4.1% risk)
- **Target:** $188.10 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 162
- **Position Value:** $29,273.40
- **Portfolio %:** 29.27%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-24 (Est: $1.46)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.65 | $1.82 | +10.1% |
| 2025Q2 | $1.66 | $0.78 | -53.0% |
| 2025Q1 | $1.57 | $1.04 | -33.7% |
| 2024Q4 | $1.98 | $2.62 | +32.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*